Chemical Compound

Rovazolac

CAS Registry Number 1454288-88-0
Rovazolac chemical structure
Primary Record

Rovazolac

In stock
5,650 g
Purity
98.7 %
CAS
1454288-88-0

Compound Identifiers & Properties

CAS
1454288-88-0
PubChem CID
89792952
SMILES
CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C
Canonical SMILES
CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1

Names & Synonyms

  • Rovazolac
  • Pagibaximab
  • pagibaximabum
  • Rovazolac [INN]
  • 1454288-88-0
  • ROVAZOLAC [USAN]
  • RefChem:858292
  • PAGIBAXIMAB [INN]
  • Pagibaximab [USAN:INN]
  • PAGIBAXIMAB [USAN]
  • ALX-101
  • W51K389XIL
  • UNII-W51K389XIL
  • BSYX-A110
  • ZUMNJDGBYXHASJ-UHFFFAOYSA-N
  • 23KB56UHN9
  • BSYX-A 110
  • GTPL9625
  • orb1706691
  • C21H19F3N2O4S
  • CHEMBL4297218
  • SCHEMBL15242823
  • DTXSID801122584
  • DTXSID901054118
  • MFCD31657370
  • AKOS040742578
  • (trifluoromethyl)-1H-pyrazol-1-yl}acetate
  • example 36 [WO2013130892]
  • A-110
  • DA-77543
  • MS-28220
  • HY-109073
  • CS-0033536
  • G16303
  • A999985
  • ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
  • ethyl {5-[3'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]-3-
  • 595566-61-3
  • ethyl 2-(5-(3'-(methylsulfonyl)biphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
  • 1H-PYRAZOLE-1-ACETIC ACID, 5-(3'-(METHYLSULFONYL)(1,1'-BIPHENYL)-4-YL)-3-(TRIFLUOROMETHYL)-, ETHYL ESTER
  • ETHYL (5-(3'-(METHANESULFONYL)(1,1'-BIPHENYL)-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)ACETATE
  • Ethyl {5-[3'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl}acetate
  • Ethyl 2-(5-(3'-(methylsulfonyl)-(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1hpyrazol-1-yl)acetate
  • ethyl 2-(5-(3'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
  • Ethyl 2-[5-[3 inverted exclamation marka-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetate
  • Ethyl 2-[5-[3a(2)-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetate
  • IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMER
  • Immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid) (human-mouse monoclonal heavy chain), disulfide with human-mouse monoclonal kappa-chain, dimer
  • IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
  • Immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid)(human-mouse monoclonal heavy chain), disulfide with human-mouse monoclonal kappa-chain, dimer
  • IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL KAPPA-CHAIN, DIMER